¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¶Çöº´ÇÐȸ Overcoming the common Difficulties in Schizophrenia Clinic : 2019-11-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¶Çöº´ÇÐȸ Overcoming the common Difficulties in Schizophrenia Clinic : 2019-11-08
±³À°ÀÏÀÚ : 2019-11-08
±³À°Àå¼Ò : °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ  
±³À°ÁÖÁ¦ : Overcoming the common Difficulties in Schizophrenia Clinic
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¶Çöº´ÇÐȸ  
´ã´çÀÚ : ÀÌÈ£¼±
¿¬¶ôó : 02-552-6677  
À̸ÞÀÏ : lhs510@hanmail.net      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í - »çÀüµî·Ï: Æò»ýȸ¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 50,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 30,000 / Á¤½Å°Ç°­°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 20,000 - ÇöÀåµî·Ï: Á¤È¸¿ø ¸éÁ¦ / Àü¹®ÀÇ, ±³¼ö(PhD) 60,000 / Àü°øÀÇ ¹× ±ºÀü¹®ÀÇ, ÀÏ¹Ý 40,000 / Á¤½Å°Ç°­°ü·Ã ±Ù¹«ÀÚ¡¤´ëÇлý¡¤´ëÇпø»ý 30,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 09:50~11:05 Very late-onset schizophrenia-like psychosis  ÀÌÁß¼±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:05~11:20 how to deal with clinical high risk (CHR) individulas  ÀÌÅ¿µ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:20~11:30 Dopamine supersensitivety psychosis: a cause of treatment resistant schizophrenia  ±èÀÇÅÂ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:30~11:40 Pseudo-resistant schizophrenia due to non-adherence  À̽ÂÀç(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 11:40~11:50 Lauguage processing brain and its associations with verbal ability and positive symptoms in first-onset psychosis  ¹æ¹ÎÁö(Â÷ÀÇÀü¿ø) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:00~14:30 Antipsychotiocs-induced obsessive-compulsive symptoms  ÀÌÁØÈñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:30~14:50 tardive movement disorders  ÀÌÁ¤¼®(±¹¹Î°Ç°­º¸ÇèÀϻ꺴¿ø) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:50~15:10 Hyperprolactinemia and related hormonal disturbances  À̺ÐÈñ(¸¶À½°ú¸¶À» Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:10~15:30 Antipsychotics-induced restless legs syndrome  °­½Â°É(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:40~16:00 Á¶Çöº´ ³«Àΰú Á¤½ÅÀÇ·á¼­ºñ½º ÀÌ¿ë  ÀÌÀ¯»ó(¿ëÀκ´¿ø) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 16:00~16:30 Á¤½Å°Ç°­ °ü·Ã ÀÏ°£Áö ±â»ç ºÐ¼®[¿¬±¸±â±Ý ¼öÇý°úÁ¦]  À¯½ÂÇü(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 16:30~17:00 ´ëÁ߸ÅüÀÇ Á¶Çöº´ ³«ÀÎ ½ÇÅÂ¿Í ±Øº¹  ±è¼º¿Ï(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 17:00~17:20 ¾ð·Ð ÀÔÀå¿¡¼­ º» Á¶Çöº´  ±Ç´ëÀÍ(Çѱ¹ÀϺ¸) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 09:50~11:50 Talking about voices: How to structure a helpful conversation  Mark Hayward(University of Sussex, UK) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:00~14:20 Clinical features and prevalence of metabolic syndrome in schizophrenia  ÇѱԸ¸(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:20~14:40 Biological mechanisms of metabolic syndrome in schizophrenia  ±è¼¼Çö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 14:40~15:00 Pharmacological management of metabolic syndrome in schizophrenia  À̽ÂÀº(µ¿±¹ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 11-08 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ/À±º´ÁÖȦ 15:00~15:30 Non-pharmacological management of metabolic syndromen in schizophrenia  °­½ÃÇö(±¹¸³Á¤½Å°Ç°­¼¾ÅÍ) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¶Çöº´ÇÐȸ Overcoming the common Difficulties in Schizophrenia Clinic : 2019-11-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦12Â÷ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Çмú´ëȸ ¹× 2019 ±¹Á¦Çмú´ëȸ : 2019-11-08
´ÙÀ½±Û ´ëÇѼºÇü¿Ü°úÇÐȸ PRS KOREA 2019 : 2019-11-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20896 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 81 2024-05-28
20895 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 56 2024-05-28
20894 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 13 2024-05-28
20893 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 32 2024-05-28
20892 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 44 2024-05-28
20891 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 53 2024-05-28
20890 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 151 2024-05-27
20889 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 85 2024-05-27
20888 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 194 2024-05-27
20887 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 79 2024-05-27
20886 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 36 2024-05-27
20885 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 56 2024-05-27
20884 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 72 2024-05-27
20883 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 47 2024-05-27
20882 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 50 2024-05-27
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷